Netherlands (NL)

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014 (2018) Dittmar D, Uter W, Bauer A, Fortina AB, Bircher AJ, Czarnecka-Operacz M, Dugonik A, et al. Journal article Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study (2018) Corsonello A, Tap L, Roller-Wirnsberger R, Wirnsberger G, Zoccali C, Kostka T, Guligowska A, et al. Journal article Determinants of Incident Malnutrition in Community-Dwelling Older Adults: A MaNuEL Multicohort Meta-Analysis (2018) Streicher M, Van Zwienen J, Bardon L, Nagel G, Teh R, Meisinger C, Colombo M, et al. Journal article Complex lipid globules in early-life nutrition improve long-term metabolic phenotype in intra-uterine growth-restricted rats (2018) Teller IC, Hoyer-Kuhn H, Broenneke H, Nosthoff-Horstmann P, Oosting A, Lippach G, Wohlfarth M, et al. Journal article A proposal to create an extension to the European baseline series (2018) Wilkinson M, Gallo R, Goossens A, Johansen JD, Rustemeyer T, Sanchez-Perez J, Schuttelaar ML, Uter W Journal article Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23 (2018) Martinez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramirez-Alejo N, Mele F, Latorre D, et al. Journal article From design to the clinic: practical guidelines for translating cardiovascular nanomedicine (2018) Cicha I, Chauvierre C, Texier I, Cabella C, Metselaar JM, Szebeni J, Dezsi L, et al. Journal article WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to dusts and/or fibres and of the effect of occupational exposure to dusts and/or fibres on pneumoconiosis (2018) Mandrioli D, Schlunssen V, Adam B, Cohen RA, Colosio C, Chen W, Fischer A, et al. Journal article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article